US Stock MarketDetailed Quotes

MBRX Moleculin Biotech

Watchlist
  • 2.3600
  • -0.0400-1.67%
Close Sep 9 16:00 ET
  • 2.3600
  • 0.00000.00%
Post 20:02 ET
6.71MMarket Cap-202P/E (TTM)

Moleculin Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.53%6.19M
-20.07%6.68M
-3.29%29.63M
26.55%8.92M
-34.53%5.95M
-13.76%6.41M
18.09%8.35M
33.40%30.64M
35.41%7.05M
47.54%9.08M
Selling and administrative expenses
-17.17%2.06M
-9.25%2.39M
-13.21%10.02M
-20.65%2.25M
-14.64%2.64M
-22.03%2.49M
8.88%2.64M
37.63%11.54M
42.47%2.84M
52.75%3.09M
-General and administrative expense
-17.17%2.06M
-9.25%2.39M
-13.21%10.02M
-20.65%2.25M
-14.64%2.64M
-22.03%2.49M
8.88%2.64M
37.63%11.54M
42.47%2.84M
52.75%3.09M
Research and development costs
5.20%4.09M
-25.23%4.25M
2.74%19.49M
58.74%6.63M
-45.01%3.28M
-7.52%3.89M
23.10%5.69M
31.56%18.97M
31.42%4.18M
45.67%5.97M
Depreciation amortization depletion
0.00%31K
6.67%32K
-2.31%127K
9.38%35K
0.00%32K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-21.95%32K
-Depreciation and amortization
0.00%31K
6.67%32K
-2.31%127K
9.38%35K
0.00%32K
-8.82%31K
-6.25%30K
-20.73%130K
-5.88%32K
-21.95%32K
Operating profit
3.53%-6.19M
20.07%-6.68M
3.29%-29.63M
-26.55%-8.92M
34.53%-5.95M
13.76%-6.41M
-18.09%-8.35M
-33.40%-30.64M
-35.41%-7.05M
-47.54%-9.08M
Net non-operating interest income expense
-59.23%159K
-38.52%241K
470.00%1.37M
107.94%262K
881.82%324K
900.00%390K
833.33%392K
-21.57%240K
80.00%126K
-62.07%33K
Non-operating interest income
-59.23%159K
-38.52%241K
470.00%1.37M
107.94%262K
881.82%324K
900.00%390K
833.33%392K
-21.57%240K
--126K
--33K
Other net income (expense)
3,693.33%1.71M
3,019.15%1.47M
-209.53%-1.51M
-1,160.53%-1.61M
-96.82%14K
-92.72%45K
-71.52%47K
-79.68%1.38M
-93.42%152K
-73.98%440K
Gain on sale of security
4,611.11%1.7M
3,630.77%1.46M
-178.20%-1.04M
-841.72%-1.12M
-99.76%1K
-94.03%36K
-75.63%39K
-80.16%1.34M
-93.43%151K
-74.91%421K
Other non- operating income (expenses)
22.22%11K
37.50%11K
-1,255.00%-462K
-49,300.00%-492K
-31.58%13K
-40.00%9K
60.00%8K
0.00%40K
-90.00%1K
46.15%19K
Income before tax
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
Income tax
Net income
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
Net income continuous Operations
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
Minority interest income
Net income attributable to the parent company
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.73%-4.32M
37.21%-4.97M
-2.56%-29.77M
-51.68%-10.27M
34.86%-5.61M
11.82%-5.98M
-15.26%-7.92M
-82.62%-29.03M
-139.65%-6.77M
-96.64%-8.61M
Basic earnings per share
43.71%-1.7
51.09%-2.02
0.99%-15.1454
-45.86%-5.2454
36.67%-2.85
16.11%-3.02
-14.72%-4.13
-72.84%-15.2961
-166.38%-3.5961
-100.00%-4.5
Diluted earnings per share
43.71%-1.7
51.09%-2.02
0.99%-15.1454
-45.86%-5.2454
36.67%-2.85
16.11%-3.02
-14.72%-4.13
-72.84%-15.2961
-166.38%-3.5961
-100.00%-4.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.53%6.19M-20.07%6.68M-3.29%29.63M26.55%8.92M-34.53%5.95M-13.76%6.41M18.09%8.35M33.40%30.64M35.41%7.05M47.54%9.08M
Selling and administrative expenses -17.17%2.06M-9.25%2.39M-13.21%10.02M-20.65%2.25M-14.64%2.64M-22.03%2.49M8.88%2.64M37.63%11.54M42.47%2.84M52.75%3.09M
-General and administrative expense -17.17%2.06M-9.25%2.39M-13.21%10.02M-20.65%2.25M-14.64%2.64M-22.03%2.49M8.88%2.64M37.63%11.54M42.47%2.84M52.75%3.09M
Research and development costs 5.20%4.09M-25.23%4.25M2.74%19.49M58.74%6.63M-45.01%3.28M-7.52%3.89M23.10%5.69M31.56%18.97M31.42%4.18M45.67%5.97M
Depreciation amortization depletion 0.00%31K6.67%32K-2.31%127K9.38%35K0.00%32K-8.82%31K-6.25%30K-20.73%130K-5.88%32K-21.95%32K
-Depreciation and amortization 0.00%31K6.67%32K-2.31%127K9.38%35K0.00%32K-8.82%31K-6.25%30K-20.73%130K-5.88%32K-21.95%32K
Operating profit 3.53%-6.19M20.07%-6.68M3.29%-29.63M-26.55%-8.92M34.53%-5.95M13.76%-6.41M-18.09%-8.35M-33.40%-30.64M-35.41%-7.05M-47.54%-9.08M
Net non-operating interest income expense -59.23%159K-38.52%241K470.00%1.37M107.94%262K881.82%324K900.00%390K833.33%392K-21.57%240K80.00%126K-62.07%33K
Non-operating interest income -59.23%159K-38.52%241K470.00%1.37M107.94%262K881.82%324K900.00%390K833.33%392K-21.57%240K--126K--33K
Other net income (expense) 3,693.33%1.71M3,019.15%1.47M-209.53%-1.51M-1,160.53%-1.61M-96.82%14K-92.72%45K-71.52%47K-79.68%1.38M-93.42%152K-73.98%440K
Gain on sale of security 4,611.11%1.7M3,630.77%1.46M-178.20%-1.04M-841.72%-1.12M-99.76%1K-94.03%36K-75.63%39K-80.16%1.34M-93.43%151K-74.91%421K
Other non- operating income (expenses) 22.22%11K37.50%11K-1,255.00%-462K-49,300.00%-492K-31.58%13K-40.00%9K60.00%8K0.00%40K-90.00%1K46.15%19K
Income before tax 27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M
Income tax
Net income 27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M
Net income continuous Operations 27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M
Minority interest income
Net income attributable to the parent company 27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.73%-4.32M37.21%-4.97M-2.56%-29.77M-51.68%-10.27M34.86%-5.61M11.82%-5.98M-15.26%-7.92M-82.62%-29.03M-139.65%-6.77M-96.64%-8.61M
Basic earnings per share 43.71%-1.751.09%-2.020.99%-15.1454-45.86%-5.245436.67%-2.8516.11%-3.02-14.72%-4.13-72.84%-15.2961-166.38%-3.5961-100.00%-4.5
Diluted earnings per share 43.71%-1.751.09%-2.020.99%-15.1454-45.86%-5.245436.67%-2.8516.11%-3.02-14.72%-4.13-72.84%-15.2961-166.38%-3.5961-100.00%-4.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg